Last reviewed · How we verify

NCT06153745

Aspheric Monofocal Intraocular Lens in Pediatric Patients

Completed Last updated 22 July 2024
What this trial tests

trial testing Tecnis Eyhance ICB00 intraocular lens (Johnson&Johnson Vision, Santa Ana, California USA) in Cataract in Child in 13 participants. Completed in 31 July 2023.

Timeline
1 January 2023
Primary endpoint
31 July 2023
31 July 2023

Quick facts

Lead sponsorLuca Buzzonetti
StatusCompleted
Study typeOBSERVATIONAL
Enrollment13
Start date1 January 2023
Primary completion31 July 2023
Estimated completion31 July 2023
Sites1 location across Italy

Drugs / interventions tested

Conditions studied

Sponsor

Luca Buzzonetti

Who can join

Adults 6 to 13, any sex, with Cataract in Child. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To evaluate the performance a new aspheric monofocal intraocular lens (IOL) with higher order aspheric optic for far, intermediate, and near vision, in pediatric patients after monolateral cataract surgery.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Luca Buzzonetti trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06153745.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing